SCHEMBL1587972

SCHEMBL1587972

COCCNC(=O)c1ccc(C(=O)OC)s1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.50
MAPK1 P28482 4/20 0.50
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 2/20 0.48
NPSR1 Q6W5P4 3/20 0.47
LMNA P02545 2/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C19 P33261 2/20 0.47
ABL1 P00519 1/20 0.47
CYP1A2 P05177 1/20 0.47
RIN1 Q13671 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5327824 0.90 MAPK1 (0.51) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL1587865 0.87 HPGD (0.50) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL2001834 0.87 NPSR1 (0.50) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL12124264 0.83 POLB (0.61) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL16011515 0.83 HDAC1 (0.61) HPGDMAPK1KDM4EALDH1A1RAB9A
SCHEMBL2201378 0.81 HDAC1 (0.68) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL12313386 0.81 HPGD (0.56) HPGDMAPK1KDM4EALDH1A1NPC1
SCHEMBL6455155 0.80 HDAC3 (0.65) ALDH1A1NPC1RAB9ASMN1; SMN2GAA
SCHEMBL8593304 0.80 SMN1; SMN2 (0.46) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL70027 0.80 NPSR1 (0.67) HPGDMAPK1KDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904488-B1 PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL IND LTD (JP) 2013-03-06 EP disclosed
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 US disclosed
US-7960425-B2 Pyrazole compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-14 US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 US disclosed
US-20090131676-A1 PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 US disclosed
EP-1904472-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2008-04-02 EP disclosed
EP-1904488-A1 PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2008-04-02 EP disclosed
WO-2007011056-A1 PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 WO disclosed
WO-2007010954-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HPGD 2277/4885MAPK1 853/4885KDM4E 3583/4885
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HPGD 2277/4885MAPK1 853/4885KDM4E 3583/4885
US-20090131676-A1 PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS MPL, THPO, TEK HPGD 1155/4885MAPK1 446/4885KDM4E 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.